1. What are the most important issues throughout Dole’s DBCP history? Did Dole appropriately balance economic and ethical considerations in its decision-making? 
2. Who are the principal stakeholders of the company? Did Dole treat them differently, and if so, why? What were the key challenges for the company in managing the relationship with those different stakeholder groups? 
3. How would you as the top executive of the company handle the situation that pleading guilty in the DBCP cases and rectifying your mistakes from the past could severely harm the company’s financial stability?
4. The case tells us that although DBCP was prohibited in the United States, it was legally still possible to manufacture and export the pesticide. Dole took advantage of that situation and used it on many of its plantations in Central America. Some authors have pointed out the fact that when Dole used DBCP in Nicaragua, the local worker compensation system “didn’t even recognize sterility as a possible injury, and therefore offered no compensation.” From that perspective, Dole was in compliance with Nicaraguan and U.S. law. Is legal compliance the only responsibility that should matter in such situations? Can you identify any additional responsibilities that play a role in the Dole case?